CHINA RESOURCES PHARMACEUTICAL (CRPGF)

0.5600 0.0000 (0.00%) As of 10:23AM EDT. Market open.

CHINA RESOURCES PHARMACEUTICAL

China Resources Building
41st Floor Room 4104–05 26 Harbour Road
Wan Chai
Hong Kong
852 2593 8991
https://www.crpharm.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 72,986

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Xiaosong Bai	CEO & Executive Director	368.92k	N/A	1971
Mr. Ran Tao	VP & Executive Director	399.59k	N/A	1965
Madam Rong Deng	CFO & Executive Director	N/A	N/A	1978
Ms. Lu Ge	Chief Information Officer & VP	N/A	N/A	1971
Ms. Na Tang	Chief Legal Advisor	N/A	N/A	1977
Ms. Kwai Yuk Cheng	Company Secretary	N/A	N/A	N/A
Mr. Jianjun Wu	Vice President	N/A	N/A	1972
Mr. Kai Qiu	Vice President of CR Pharma & Chairman of China Resources Boya	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and v, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. It provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the CR Care and Teck Soon Hong brands. It distributes its products to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.

Corporate governance

CHINA RESOURCES PHARMACEUTICAL ’s ISS governance QualityScore as of 29 April 2024 is 2. The pillar scores are Audit: 4; Board: 1; Shareholder rights: 8; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.